Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury
Clinical trial NCT04412057 · COMPLETED
Trial details
- NCT number
- NCT04412057
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-17
- Primary completion
- 2020-12-14
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.